Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Helfand

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated miceUsha Stiefel, Jaana Harmoinen, Pertti Koski, et al.
Biochemistry|January 28, 2004
Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structurePius S Padayatti, Marion S Helfand, Monica A Totir, et al.
Journal of Drug Targeting|January 1, 1994
Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress reviewE G MacEwen, I D Kurzman, S Helfand, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Role of Asp104 in the SHV beta-lactamaseChristopher R Bethel, Andrea M Hujer, Kristine M Hujer, et al.
The Journal of Biological Chemistry|February 6, 2004
Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibitionDoritza Pagan-Rodriguez, Xiang Zhou, Reiko Simmons, et al.
Journal of the American Chemical Society|October 5, 2006
Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfonePius S Padayatti, Anjaneyulu Sheri, Monica A Totir, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymesKristine M Hujer, Nashaat S Hamza, Andrea M Hujer, et al.
The Journal of Biological Chemistry|July 1, 2005
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibitionDeley Sulton, Doritza Pagan-Rodriguez, Xiang Zhou, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
Inhibition of OXA-1 beta-lactamase by penemsChristopher R Bethel, Anne M Distler, Mark W Ruszczycky, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated miceUsha Stiefel, Jaana Harmoinen, Pertti Koski, et al.
Biochemistry|January 28, 2004
Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structurePius S Padayatti, Marion S Helfand, Monica A Totir, et al.
Journal of Drug Targeting|January 1, 1994
Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress reviewE G MacEwen, I D Kurzman, S Helfand, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Role of Asp104 in the SHV beta-lactamaseChristopher R Bethel, Andrea M Hujer, Kristine M Hujer, et al.
The Journal of Biological Chemistry|February 6, 2004
Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibitionDoritza Pagan-Rodriguez, Xiang Zhou, Reiko Simmons, et al.
Journal of the American Chemical Society|October 5, 2006
Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfonePius S Padayatti, Anjaneyulu Sheri, Monica A Totir, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymesKristine M Hujer, Nashaat S Hamza, Andrea M Hujer, et al.
The Journal of Biological Chemistry|July 1, 2005
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibitionDeley Sulton, Doritza Pagan-Rodriguez, Xiang Zhou, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
Inhibition of OXA-1 beta-lactamase by penemsChristopher R Bethel, Anne M Distler, Mark W Ruszczycky, et al.
Pageof 4